Omi et al. have reported that 3 of 7 uterine adenosarcomas had cyclin D1 immunoreactivity (2 had a high-grade morphology and SOG, and one was a low-grade type without SOG) (7). This evidence concerns the gene CCND1 and uterine corpus adenosarcoma.